TritonPoint Wealth’s Boston Scientific BSX Stock Holding History

TritonPoint Wealth’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,048	Closed	-$291K	–	272
2025 Q4	$291K	Sell	3,048 -455	-13%	-$44.6K	0.03%	221
2025 Q3	$342K	Buy	3,503 +136	+4%	+$14.1K	0.03%	276
2025 Q2	$362K	Buy	3,367 +43	+1%	+$4.35K	0.03%	260
2025 Q1	$335K	Buy	3,324 +284	+9%	+$28.6K	0.03%	258
2024 Q4	$271K	Buy	3,040 +279	+10%	+$24.6K	0.02%	284
2024 Q3	$230K	Buy	+2,761	New	+$218K	0.02%	307

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TritonPoint Wealth's BSX Position: Q1 2026 in Review

TritonPoint Wealth sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,048 shares — an estimated $291K sold.

TritonPoint Wealth first reported a position in BSX in Q3 2024 and held it in 6 quarters. The position peaked at $362K in Q2 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

TritonPoint Wealth reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
TritonPoint Wealth sold 3,048 Boston Scientific shares in Q1 2026, an estimated $291K.
TritonPoint Wealth first reported a position in Boston Scientific in Q3 2024 and held it in 6 quarters.
TritonPoint Wealth's Boston Scientific position peaked at $362K in Q2 2025.
1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on TritonPoint Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.